Objective: Snakebite envenoming remains a public health threat in many tropical countries. While community knowledge of local snakes and snakebite first‐aid and prevention are needed to reduce snakebite incidence and improve the outcomes for snakebite patients, it is poor in many communities. We assessed community health workers and community members regarding their knowledge on local snakes, snakebite first‐aid and prevention in Neno district, Malawi. Methods: In November 2022, we conducted a cross‐sectional survey among 312 community health workers and 379 community members in the Neno District of Malawi to assess their knowledge of snake identification, snakebite first‐aid, and prevention. Different questions were asked in these sections and summarised as linear scores ranging from 0% to 100%. Scores of 0%–49%, 50%–70%, and >70% were considered inadequate, fairly adequate, and adequate, respectively. Along with data collected during knowledge assessments, the socio‐demographic characteristics of participants were collected. To assess knowledge differences between community health workers and community members, Pearson's chi‐square or Fisher's exact tests were used, and linear regression was calculated to investigate possible predictors of knowledge. Results: Overall, 66.6% of participants were females with a median age of 39 (IQR = 30–48) years. Of the 89% ( n = 615) who agreed to view snake pictures, only 1.3% had adequate snake identification knowledge. Less than 5% ( n = 33) had adequate knowledge of first aid measures, and 14.3% ( n = 99) had adequate knowledge of prevention practices. Overall, less than 1% ( n = 3) had adequate knowledge across the three assessment sections, with no significant difference between community health workers ( n = 1, 0.3%) and community members ( n = 2, 0.5%) ( p > 0.949). Conclusion: Both community health workers and community members had inadequate knowledge regarding local snake species, first aid for snakebites and prevention measures. The effect of awareness campaigns and other education initiatives could be explored to help improve these gaps.
Data on incidence of snakebites and the responsible snake species are largely missing in Vietnam and comprehensive national guidelines for management of snakebite envenoming are not yet available. They are needed to estimate the scope of this health problem, to assess the demand for snake antivenom and to ensure the best possible treatment for snakebite victims. A cross-sectional community-based survey was conducted from January to April 2018. Multistage cluster sampling was applied and snakebite incidence in Can Tho municipality, excluding two central districts of Can Tho city, was calculated at 48 (95%-confidence interval (CI): 20.5–99.8) snakebites per 100,000 person-years. Seven snakebite victims found during the survey reported 3 bites from green pit vipers and 4 bites from non-venomous snakes. In 2017 two treatment centres for snakebite envenoming in Can Tho city, the Military Hospital 121 and the Paediatric Hospital, received 520 admissions of snakebite victims. Two hundred sixty-seven came from Can Tho Municipality and 253 from neighbouring provinces. According to these data, the incidence of snakebites for Can Tho municipality was calculated at 21 (95%-CI: 18.5–23.7) snakebites per 100,000 person-years. Incidence was 14 (95%-CI: 12–17) snakebites per 100,000 person years in those 7 districts of the municipality which were part of the community survey. Green pit vipers were responsible for 92% of snakebite envenoming. Antivenom, antibiotics and corticosteroids were administered to 405 (90%), 379 (84%), and 310 (69%) out of 450 patients, respectively. Incidence of snakebites in Can Tho Municipality is relatively low and green pit vipers are responsible for the vast majority of bites. Approximately one third of snakebite patients sought medical care in hospitals and although hospital data still underestimate the real incidence of snakebites, these statistics are valuable and can be obtained fast and inexpensively. Evaluation of patients’ records indicates the need for development of guidelines for management of snakebite envenoming in Vietnam to ensure a rational use of antivenom and ancillary treatments. The World Health Organization included snakebite envenoming into the list of neglected tropical diseases in 2017 and launched a strategy for prevention and control of snakebite envenoming in 2019 in order to reduce the number of deaths and cases of disability by 50% before 2030. The neglect includes first and foremost epidemiology of snakebites, knowledge about management of snakebite envenoming and the medically relevant snake fauna, and access to life saving treatment with snake antivenom. In Vietnam reliable data on snakebite incidence and on snake species responsible for envenoming are largely missing. The present community-based survey showed that incidence of snakebites in Can Tho Municipality in the Mekong Delta in South Vietnam is significantly lower than in neighbouring countries and lower poverty rates among others are most likely the principal reason. Green pit vipers are responsible for the vast majority of snakebites. Treatment practices need to be reviewed and national guidelines are needed to achieve the best outcome for snakebite patients.
Snake antivenom is the only specific treatment for snakebite envenoming, but life-threatening anaphylaxis is a severe side effect and drawback for the use of these typically mammalian serum products. The present study investigates the hypotheses whether serum IgE antibodies against the epitope galactose-alpha-1,3-galactose (α-gal) located on the heavy chain of non-primate mammalian antibodies are a possible cause for hypersensitivity reactions to snake antivenom. Serum samples from 55 patients with snakebite envenoming were obtained before administration of snake antivenom and tested for serum IgE (sIgE) against α-gal and total IgE. Early anaphylactic reactions (EARs) during the first 3 h after antivenom administration were classified into mild, moderate or severe and correlated with the presence of sIgE against α-gal. Fifteen (27%) out of 55 patients (37 male, 18 female, median 34 years, range 9–90 years) developed EARs after antivenom administration. Eleven, three and one patients had mild, moderate and severe EARs, respectively. Serum IgE against α-gal was detected in 17 patients (31%); in five (33%) out of 15 patients with EARs and in 12 (30%) out of 40 patients without EAR (Odds Ratio = 1.2; 95%-confidence interval: 0.3–4.2) with no correlation to severity. Although the prevalence of serum IgE against α-gal was high in the study population, very high levels of total IgE in the majority of patients question their clinical relevance and rather indicate unspecific sIgE binding instead of allergy. Lack of correlation between α-gal sIgE and EARs together with significantly increased total IgE levels suggest that sIgE against α-gal is not the major trigger for hypersensitivity reactions against snake antivenom.
Neuromuscular paralysis because of snakebite envenoming is a life-threatening and common clinical syndrome caused by most elapids (family Elapidae) and few species of pit vipers and true vipers (family Viperidae) [1]. In Southeast Asia, cobras and kraits are responsible for most cases of neurotoxic envenoming. Two major neurotoxin classes, alpha-neurotoxins (α-NTs) and beta-neurotoxins (β-NTs), target the neuromuscular junction and cause flaccid muscle paralysis [2]. Beta-neurotoxins belong to the group I phospholipases A 2 and act at the presynaptic motor nerve terminal. They are the major neurotoxins in krait venom and cause synaptic vesicle depletion with declining acetylcholine release and degeneration of the nerve terminal [3]. Phospholipases A 2 have a molecular mass of 13 to 16 kDa which corresponds to 115 to 125 amino acids [2]. After subcutaneous injection of venom during the bite, toxins are resorbed from the interstitial space into the blood circulation either directly or through lymphatic vessels and leave the blood circulation to reach and act at the neuromuscular junction [4,5]. The small molecular size of neurotoxins facilitates the journey and most victims develop neurotoxic signs within 6 h after the bite [6]. Once neurotoxic signs are present and nerve terminals damaged, administration of antivenom will likely be ineffective. Here, we propose the administration of antivenom to all patients with a confirmed krait bite who present within the first 6 h after the bite, regardless of neurotoxic signs, and present arguments for this approach.
In 2017, the World Health Organization (WHO) added snakebite envenoming to the list of neglected tropical diseases and proposed a strategy to reduce the mortality and morbidity of snakebite envenoming by 50% by 2030. This strategy focusses on four main areas: safe and effective treatment, empowering and engaging with communities, strengthening health systems, increasing partnerships, […]